Condition 101 About Atypical Teratoid Rhabdoid Tumor

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Atypical Teratoid Rhabdoid Tumor

View All Doctors

Latest Advances On Atypical Teratoid Rhabdoid Tumor

  • Condition: Relapsed and Refractory Malignant Rhabdoid Tumor of Kidney (MRTK) and Atypical Teratoid Rhabdoid Tumor (ATRT)
  • Journal: Gan to kagaku ryoho. Cancer & chemotherapy
  • Treatment Used: Gemcitabine and Docetaxel (GEM/DTX)
  • Number of Patients: 4
  • Published —
These case reports describe the use of gemcitabine and docetaxel (GEM/DTX) chemotherapy in the treatment of patients with malignant rhabdoid tumor of the kidney (MRTK) and atypical teratoid rhabdoid tumor (ATRT).
  • Condition: Metastatic Atypical Teratoid/Rhabdoid Tumors
  • Journal: Pediatric neurology
  • Treatment Used: Autologous Hematopoietic Cell Rescue, Radiation Therapy, and Intrathecal Chemotherapy
  • Number of Patients: 130
  • Published —
This study investigated various treatment modalities in patients with metastatic atypical teratoid/rhabdoid tumors.
View All Latest Advances

Clinical Trials For Atypical Teratoid Rhabdoid Tumor

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 30
  • Start Date: April 30, 2019
An Open-Label, Dose Escalation, Efficacy, and Safety Study of CLR 131 in Children, Adolescents, and Young Adults With Select Solid Tumors, Lymphoma, and Malignant Brain Tumors
Clinical Trial
  • Status: Recruiting
  • Participants: 1650
  • Start Date: August 21, 2017
Exploring Outcomes and Risk in Patients With Rare Central Nervous System Tumors
View All Clinical Trials